IGF1 and breast carcinoma: The type I insulin-like growth factor receptor (IGF1R) is overexpressed by many breast cancer cell lines and high levels of IGF1 are associated with poor prognosis in breast cancer (Huynh et al, 1993; Peyrat et al, 1993).